Drawing for TOXLINK

USPTO serial 79266897

TOXLINK

Reviewed by CopyMark Law Group

Reg. 6279457Status 700Renewal
Filing date
Status date
Registration date
Mar 2, 2021
Examiner
MACFARLANE, JAMES W
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TOXLINK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michele H. Bowman

Michele H. Bowman Abbott Laboratories100 Abbott Park RoadAbbott Park, IL 60064UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic reagents and chemical reagents, not for medical purposes; immunodiagnostic reagents, not for medical purposes; buffer solutions, not for medical purposes; immunoassay chemical test strips, not for medical purposes; drug testing kits comprising diagnostic and chemical reagents and assays, not for medical purposes; alcohol testing kits comprising diagnostic and chemical reagents and assays, not for medical purposes; drug testing kits comprised of diagnostic reagents and assays for testing body fluids, not for medical purposes; kits comprising diagnostic and chemical reagents and assays for testing for the presence of analytes in biological fluids, other fluids and other matrices, not for medical purposes; kits comprising diagnostic and chemical reagents and assays for collecting and testing oral fluid for the presence of drugs and drug metabolites, not for medical purposes; kits comprising diagnostic and chemical reagents and assays for collecting and testing oral fluid for the presence of alcohol and alcohol metabolites, not for medical purposes; rapid drug screening tests comprised of diagnostic and chemical reagents for the simultaneous, qualitative detection of multiple drugs and/or metabolites in human urine, not for medical purposesACTIVE—
005Diagnostic reagents and chemical reagents, for medical purposes; medical diagnostic and immunodiagnostic reagents, for medical purposes; drug and alcohol testing kits comprising diagnostic and chemical reagents and assays, for medical purposes; drug and alcohol testing kits comprised of diagnostic reagents and assays for testing body fluids, for medical purposes; kits comprising diagnostic and chemical reagents and assays for testing for the presence of analytes in biological fluids, other fluids and other matrices, for medical purposes; kits comprising diagnostic and chemical reagents and assays for collecting and testing oral fluid for the presence of drugs and drug metabolites, for medical purposes; kits comprising diagnostic and chemical reagents and assays for collecting and testing oral fluid for the presence of alcohol and alcohol metabolites, for medical purposes; rapid drug screening tests comprised of diagnostic and chemical reagents for the simultaneous, qualitative detection of multiple drugs and/or metabolites in human urine, for medical purposesACTIVE—
009Downloadable software for administering, scanning, interpreting, and reporting and information in the fields of toxicology, forensics, drug testing, and alcohol testing; downloadable mobile applications for administering, scanning, interpreting, and reporting data and information in the fields of toxicology, forensics, drug testing, and alcohol testing; downloadable software and downloadable mobile applications for administering, scanning, and interpreting results of rapid drug screening devices; downloadable software and downloadable mobile applications for administering, scanning, and interpreting results of rapid alcohol screening devices; drug testing cups for laboratory use for the detection of drugs in blood or other bodily fluids, not for medical purposes; alcohol testing cups for laboratory use for the detection of alcohol in blood or other bodily fluids, not for medical purposes; laboratory devices for analyzing blood and other bodily fluids, for drug and alcohol screening and testing, not for medical purposes; laboratory devices for rapid drug screening testing, not for medical purposes, for the simultaneous, qualitative detection of multiple drugs and/or metabolites in human urine; forensic drug and alcohol testing kits comprising non-medical laboratory devices for analyzing blood and other bodily fluids, not for medical purposes; forensic kits comprising non-medical laboratory devices for testing for the presence of analytes in biological fluids, other fluids and other matrices, not for medical purposes; kits comprising non-medical laboratory devices for collecting and testing biological fluid for the presence of drugs and drug metabolites, not for medical purposes; kits comprising non-medical laboratory devices for collecting and testing biological fluid for the presence of alcohol and metabolites, not for medical purposesACTIVE—
010Medical apparatus and instruments for the screening of drugs and alcohol, namely, medical diagnostic devices for analyzing blood and other bodily fluids for the presence of drugs and alcohol; medical diagnostic and immunodiagnostic apparatus and instruments for the screening of drugs and alcohol, for analyzing blood and other bodily fluids for the presence of drugs and alcohol; drug and alcohol testing analyzers for medical purposes, for analyzing blood and other bodily fluids for the presence of drugs and alcohol; drug and alcohol testing cups, namely, testing cups featuring rapid lateral flow chromatographic immunoassays for drug and alcohol screening purposes, for medical purposes; drug and alcohol testing instruments for medical purposes, for analyzing blood and other bodily fluids for the presence of drugs and alcohol; drug and alcohol testing systems comprising medical apparatus and instruments for medical purposes, for analyzing blood and other bodily fluids for the presence of drugs and alcohol; medical drug testing kits comprising medical apparatus and instruments, for analyzing blood and other bodily fluids for the presence of drugs; medical alcohol testing kits comprising medical apparatus and instruments, for analyzing blood and other bodily fluids for the presence of alcohol; kits comprising medical apparatus and instruments for testing for the presence of analytes in biological fluids, other fluids and other matrices, all for medical purposes; kits comprising medical apparatus and instruments for collecting and testing biological fluid for the presence of drugs and drug metabolites, for medical use; kits comprising medical apparatus and instruments for collecting and testing biological fluid for the presence of alcohol and alcohol metabolites, for medical use; drug testing cups for use in drug screening of urine; alcohol testing cups for use in alcohol screening of urine; drug screening testing apparatus for medical use, for analyzing blood and other bodily fluids for the presence of drugs; alcohol screening testing apparatus for medical use, for analyzing blood and other bodily fluids for the presence of alcohol; rapid drug screening testing apparatus for the simultaneous, qualitative detection of multiple drugs and/or metabolites in human urine, for medical purposesACTIVE—
042Software as a service (SAAS) services featuring online non-downloadable scientific software for use in database management and reporting in the fields of toxicology, forensics, drug testing, and alcohol testing; server hosting services for others featuring online databases for the provision of information in the fields of toxicology, forensics, drug testing, drug screening, alcohol screening, and alcohol testing; hosting online non-downloadable data management and reporting portals, namely, hosting websites for others in the fields of toxicology, forensics, drug testing, drug screening, alcohol testing, and alcohol screening; laboratory toxicology services; hosting online non-downloadable data management and reporting portals, namely, providing online non-downloadable software for others in the fields of toxicology, forensics, drug testing, drug screening, alcohol testing, and alcohol screening; laboratory toxicology services; laboratory toxicology services; laboratory drug testing services for forensic research purposes; design and development of computer software for use with medical and non-medical technologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 2, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 3, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 5, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 27, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 3, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 3, 2021FIMPFINAL DISPOSITION PROCESSED—
Jun 2, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 6, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 2, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 17, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 17, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 12, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 15, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 15, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 25, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 6, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 6, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Nov 6, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 6, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 6, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
May 7, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 7, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 7, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 14, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 14, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2020ALIEASSIGNED TO LIE—
Apr 3, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 26, 2019RFNTREFUSAL PROCESSED BY IB—
Oct 5, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 5, 2019RFRRREFUSAL PROCESSED BY MPU—
Sep 27, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 26, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 13, 2019DOCKASSIGNED TO EXAMINER—
Sep 13, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 12, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance